Form D · Biotechnology

Biolex Therapeutics, Inc.

Pittsboro, NC · CIK 0001407698

Offering snapshot reported Dec 19, 2011 · SEC filing

Reported sold
$2.36M
Offering amount: $3.2M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 6, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 19, 2011Initial$2,364,417No comparison10SEC filing
Jun 9, 2011Initial$5,899,709No comparison13SEC filing
Jul 30, 2010Initial$8,677,852No comparison13SEC filing
Feb 23, 2010Initial$10,000,000No comparison25SEC filing
Jan 8, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Jul 28, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-170312

Source: Form D, filed Dec 19, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
W. Thomas Amick Director
Kevin Bitterman Director
David L. Castaldi Director
Dennis J. Dougherty Director
Kurt Graves Director, Executive
Jeff Leiden Director
Jeffrey Leiden Director
P. Sherrill Neff Director
Liza Page Nelson Director
Liza Page Nelson Director
Dale A. Sander Executive
David Spencer Executive
Jan P. Turek Director, Executive
Klaus Veitinger Director
Glen Williams Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
158 Credle Street
Pittsboro, NC, 27312